HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

Human herpesvirus 6 (HHV-6) reactivation has been associated with acute graft-versus-host-disease (aGVHD), cytomegalovirus reactivation, and mortality after allogeneic hematopoietic cell transplantation (HCT), but previous studies have yielded inconsistent results. We performed a large prospective study of allogeneic HCT recipients in order to more definitively define the relationships between HHV-6 and these important outcomes. Plasma specimens were collected prospectively from 315 allogeneic HCT recipients and tested for HHV-6 DNA at baseline and twice weekly for 12 weeks. Cox proportional hazards models were used to evaluate the time-dependent associations between HHV-6 reactivation and the targeted outcomes. HHV-6 was detected in 111 of 315 patients (35%) at a median of 20 days after HCT. HHV-6 reactivation was associated with subsequent cytomegalovirus reactivation (adjusted hazard ratio [aHR], 1.9; 95% confidence interval [CI], 1.3-2.8; P = .002). High-level HHV-6 (>1,000 HHV-6 DNA copies/mL) was associated with subsequent grades II to IV aGVHD (aHR, 2.4; 95% CI, 1.60-3.6; P < .001). High-level HHV-6 reactivation was also associated with nonrelapse mortality (aHR, 2.7; 95% CI, 1.2-6.3; P = .02). HHV-6 reactivation was independently and quantitatively associated with increased risk of subsequent cytomegalovirus reactivation, aGVHD, and mortality after HCT. A randomized antiviral trial is warranted to establish causality between HHV-6 and these endpoints and to determine if reducing HHV-6 reactivation will improve outcome after HCT.

• Publication year

  2012

• Venue

  Biology of Blood and Marrow Transplantation

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bbmt.2012.05.012PMID 22641196PMCID PMC3439599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients.

  2011cited by this paper
• An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.

  2010cited by this paper
• Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients

  2010cited by this paper
• Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.

  2009cited by this paper
• How we treat cytomegalovirus in hematopoietic cell transplant recipients.

  2009cited by this paper
• Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.

  2008influential reference
• Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients.

  2008cited by this paper
• Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation

  2008cited by this paper
• Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

  2007cited by this paper
• Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.

  2006cited by this paper
• Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.

  2006cited by this paper
• An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens.

  2006cited by this paper
• HHV-6 and the immune system: mechanisms of immunomodulation and viral escape.

  2006cited by this paper
• Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

  2006cited by this paper
• The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.

  2006cited by this paper
• Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation.

  2005cited by this paper
• Infección primaria por herpesvirus humano 6. A population-based study of primary human herpesvirus 6 infection. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, et al N Engl J Med 2005; 352 (5): 768-76

  2005cited by this paper
• A population-based study of primary human herpesvirus 6 infection.

  2005cited by this paper
• Impact of human herpesvirus‐6 after haematopoietic stem cell transplantation

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation.

  2005influential reference
• Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation

  2005cited by this paper
• Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6

  2005cited by this paper
• Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta‐herpesviruses

  2004cited by this paper
• Selective suppression of IL-12 production by human herpesvirus 6.

  2003cited by this paper
• Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients.

  2002cited by this paper
• Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.

  2002cited by this paper
• Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients

  2002cited by this paper
• Clinical impact of human herpesvirus 6 infection after liver transplantation.

  2002cited by this paper
• Gene Expression Profile of Herpesvirus-Infected T Cells Obtained Using Immunomicroarrays: Induction of Proinflammatory Mechanisms

  2001cited by this paper
• Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation

  2001cited by this paper
• Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.

  2001cited by this paper
• Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients.

  2000cited by this paper
• Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients.

  2000cited by this paper
• Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients.

  1999cited by this paper
• Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group.

  1995cited by this paper
• Seroepidemiology of human herpesvirus 6 infection in normal children and adults

  1989cited by this paper

• Clinical Impact of HHV-6B Reactivation on Engraftment and Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation.

  2026cites this paper
• Human Herpes Virus—Six Related Clinical and Functional Implications in Lung Transplant Patients: Bronco Alveolar Lavage Analysis, Coinfections, Rejection, and Survival

  2025cites this paper
• Early HHV-6 reactivation increases the risk of graft rejection after haploidentical hematopoietic cell transplantation

  2025cites this paper
• Complete Recovery From Human Herpesvirus 6 (HHV-6) Encephalomyelitis in an Immunocompetent Adult: A Rare Cause of Paraparesis and Ataxia

  2025cites this paper
• The Role of IL28B Polymorphism in Regulating Innate and Adaptive Immunity Against Viral Infection Among Allogenic Stem Cells Transplant Recipients

  2025cites this paper
• Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive review.

  2025cites this paper
• The diagnostic complexities of human herpesvirus 6 (HHV-6) infections.

  2025cites this paper
• American Society for Transplantation and Cellular Therapy Series #9: Management of HHV-6B After Hematopoietic Cell Transplantation and Chimeric Antigen Receptor (CAR)-T-Cell Therapy.

  2025cites this paper
• Identifying HHV‐6 Induced Cytopathic Effects in Bronchoalveolar Lavage Fluid Preparations to Enhance Care in Immunocompromised Patients

  2025cites this paper
• A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant

  2024cites this paper
• Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact

  2024cites this paper
• Case report: Acute HHV6B encephalitis/myelitis post CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma

  2024cites this paper
• Performance evaluation of the SMG HHV-6 Q Real-Time PCR Kit for quantitative detection and differentiation of human herpesvirus 6A and 6B

  2024cites this paper
• Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape

  2024influential citation
• Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications

  2024cites this paper
• Reactivation of a Transplant Recipient's Inherited Human Herpesvirus 6 and Implications to the Graft

  2024cites this paper
• Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantation

  2024cites this paper
• Advances and Prospect in Herpesviruses infections after Hematopoietic Cell Transplantation: Closer to the Finish Line?

  2024cites this paper
• The plasma viral communities associate with clinical profiles in a large-scale haematological patients cohort

  2024cites this paper
• 异基因造血干细胞移植后HHV-6病毒感染的临床特征分析

  2024cites this paper
• The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome

  2023cites this paper
• HHV-6 Reactivation and Disease after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis.

  2023cites this paper
• Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt

  2023cites this paper
• Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.

  2022cites this paper
• An impact of CMV and HHV-6 reactivation on the course of early period after hematopoietic stem cell transplantation in patients with hematologic malignancies

  2022cites this paper
• Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.

  2022cites this paper
• A chemical method for generating live-attenuated, replication-defective DNA viruses for vaccine development

  2022cites this paper
• Human Herpesvirus 6 Infection and Diagnostics

  2022cites this paper
• Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis

  2022cites this paper
• HHV-6 Encephalitis After Chimeric Antigen Receptor T-cell Therapy (CAR-T): 2 Case Reports and a Brief Review of the Literature

  2021cites this paper
• Post-Transplant cyclophosphamide is associated with increase in Non-CMV Herpesvirus infections in Acute leukemia and MDS patients.

  2021cites this paper
• Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome.

  2021cites this paper
• Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus

  2021influential citation
• Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications

  2021cites this paper
• Human herpes virus 6 DNAemia is associated with worse survival after ex vivo T-cell depleted hematopoietic cell transplant.

  2021cites this paper
• Hippocampal Atrophy in Pediatric Transplant Recipients with Human Herpesvirus 6B

  2021cites this paper
• Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients

  2020cites this paper
• Human herpesvirus 6A promotes glycolysis in infected T cells by activation of mTOR signaling

  2020cites this paper
• Inflammatory Cytokine Profile in Individuals with Inherited Chromosomally Integrated Human Herpesvirus 6.

  2020cites this paper
• The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant

  2020cites this paper
• HUMAN HERPES VIRUS TYPE 6 INFECTION IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE REPUBLIC OF BELARUS

  2020cites this paper
• Reducing infectious complications after allogeneic stem cell transplant

  2020cites this paper
• Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft‐versus‐host disease

  2020influential citation
• Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients

  2020cites this paper
• Retrospective case analysis of antiviral therapies for HHV‐6 encephalitis after hematopoietic stem cell transplantation

  2020cites this paper
• Human herpesvirus‐6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis

  2020cites this paper
• HERQ-9 Is a New Multiplex PCR for Differentiation and Quantification of All Nine Human Herpesviruses

  2020cites this paper
• Viral infections after allogeneic hematopoietic stem cell transplant

  2019cites this paper
• Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies.

  2019cites this paper
• Antimicrobial Drug Prophylaxis: Challenges and Controversies

  2019cites this paper
• 多重PCR法检测造血干细胞移植患者多种疱疹病毒感染

  2019cites this paper
• Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients.

  2019cites this paper
• 儿童单倍型造血干细胞移植后HHV-6病毒性脑炎二例报告并文献复习

  2019cites this paper
• Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation

  2019cites this paper
• Febrile Neutropenia in Transplant Recipients

  2018cites this paper
• High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality

  2018cites this paper
• Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.

  2018cites this paper
• Late‐phase human herpesvirus 6B reactivation in hematopoietic stem cell transplant recipients

  2018cites this paper
• Overview of Infections Complicating Pediatric Hematopoietic Cell Transplantation.

  2018cites this paper
• Chromosomal Integration by Human Herpesviruses 6A and 6B.

  2018cites this paper
• Betaherpesvirus Complications and Management During Hematopoietic Stem Cell Transplantation.

  2018cites this paper
• Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitor.

  2018cites this paper
• Advances in the Characterization of the T-Cell Response to Human Herpesvirus-6

  2018cites this paper
• Comparison of HHV-6 DNA detection in plasma and whole blood in allogeneic hematopoietic stem cell transplant recipients: frequent false-positive results for active HHV-6 infection using whole blood samples

  2018cites this paper
• Human Herpes Virus-6-Associated Encephalitis/Myelitis Mimicking Calcineurin Inhibitor-Induced Pain Syndrome in Allogeneic Stem Cell Transplantation Recipients.

  2018cites this paper
• Human Herpesvirus-6 Reactivation and Acute Graft-versus-Host Disease.

  2018cites this paper
• 96 – Infections in Hematopoietic Stem Cell Transplant Recipients

  2018cites this paper
• Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation

  2018cites this paper
• Infections in Hematology Patients

  2018cites this paper
• Molecular Monitoring of Viral Infections

  2018cites this paper
• Infections in Allogeneic Stem Cell Transplantation

  2018cites this paper
• Impacts and Challenges of Advanced Diagnostic Assays for Transplant Infectious Diseases

  2018cites this paper
• Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

  2018cites this paper
• Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

  2018cites this paper
• Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B

  2018cites this paper
• The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality.

  2017cites this paper
• Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation

  2017cites this paper
• Human Herpesvirus 6A Exhibits Restrictive Propagation with Limited Activation of the Protein Kinase R-eIF2α Stress Pathway

  2017cites this paper
• Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation

  2017cites this paper
• Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation

  2017cites this paper
• HHV6 Encephalitis in Children After Hematopoietic Stem Cell Transplantation

  2017cites this paper
• Molecular Testing for Herpes Viruses

  2017cites this paper
• Chromosomally integrated HHV-6: a new piece of the puzzle.

  2017influential citation
• The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease

  2017cites this paper
• Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6.

  2017cites this paper
• Étude de l'intégration chromosomique de l'herpèsvirus humain de type 6 et impact de son infection sur la reconnaissance des dommages aux télomères

  2016cites this paper
• Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes

  2016cites this paper
• Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation

  2016influential citation
• Risk factors for cytomegalovirus DNAemia following haploidentical stem cell transplantation and its association with host hepatitis B virus serostatus.

  2016cites this paper
• Analysis of the shedding of three β-herpesviruses DNA in Polish patients subjected to allogeneic hematopoietic stem cell transplantation: Six-year follow up.

  2016cites this paper
• Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities

  2016cites this paper
• Pathology of Hematopoietic Cell Transplantation

  2016cites this paper
• Human Herpesvirus 6A, 6B, 7, and 8 Infections After Hematopoietic Stem Cell Transplantation

  2016cites this paper
• HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.

  2016cites this paper
• The European Hematology Association Roadmap for European Hematology Research: a consensus document.

  2016cites this paper
• Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant

  2015cites this paper
• Interplay between β herpesviruses and fungal infections in transplant patients: from the bench to the bedside

  2015cites this paper
• Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: What we do and do not know

  2015cites this paper
• Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease

  2015cites this paper
• Modulatory effects on dendritic cells by human herpesvirus 6

  2015influential citation